---
title: "12 Health Care Stocks Moving In Friday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292319496.md"
description: "In Friday's pre-market session, healthcare stocks showed mixed movements. Gainers included VYNE Therapeutics (+17.9%), WORK Medical Tech (+15.34%), and NuCana (+12.09%). Conversely, losers featured SILO Pharma (-22.4%), Virax Biolabs (-18.19%), and Liminatus Pharma (-10.41%). The report highlights specific percentage changes and market caps for these listed companies."
datetime: "2026-07-10T12:05:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292319496.md)
  - [en](https://longbridge.com/en/news/292319496.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292319496.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Friday's Pre-Market Session

### Gainers

-   **VYNE Therapeutics** (NASDAQ:VYNE) stock increased by 17.9% to $0.79 during Friday's pre-market session. The company's market cap stands at $22.4 million.
-   **WORK Medical Tech Gr** (NASDAQ:WOK) shares increased by 15.34% to $2.33. The company's market cap stands at $4.8 million.
-   **NuCana** (NASDAQ:NCNA) shares increased by 12.09% to $1.39. The company's market cap stands at $5.1 million.
-   **Pennant Gr** (NASDAQ:PNTG) shares rose 11.22% to $45.0. The company's market cap stands at $1.4 billion.
-   **Cue Biopharma** (NASDAQ:CUE) stock rose 9.69% to $40.05. The market value of their outstanding shares is at $153.3 million.
-   **Jin Medical International** (NASDAQ:ZJYL) shares moved upwards by 9.39% to $1.98. The company's market cap stands at $14.1 million.

### Losers

-   **SILO Pharma** (NASDAQ:SILO) stock declined by 22.4% to $6.0 during Friday's pre-market session. The market value of their outstanding shares is at $8.3 million.
-   **Virax Biolabs Group** (NASDAQ:VRAX) shares declined by 18.19% to $5.2. The market value of their outstanding shares is at $5.0 million.
-   **Liminatus Pharma** (NASDAQ:LIMN) shares declined by 10.41% to $0.11. The market value of their outstanding shares is at $7.6 million.
-   **SciSparc** (NASDAQ:SPRC) shares fell 7.71% to $5.03. The market value of their outstanding shares is at $3.0 million.
-   **BGM Group** (NASDAQ:BGM) shares declined by 6.89% to $0.32. The market value of their outstanding shares is at $137.3 million.
-   **GlucoTrack** (NASDAQ:GCTK) stock decreased by 6.88% to $0.36. The market value of their outstanding shares is at $2.4 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [WOK.US](https://longbridge.com/en/quote/WOK.US.md)
- [VYNE.US](https://longbridge.com/en/quote/VYNE.US.md)
- [SILO.US](https://longbridge.com/en/quote/SILO.US.md)
- [LIMN.US](https://longbridge.com/en/quote/LIMN.US.md)
- [NCNA.US](https://longbridge.com/en/quote/NCNA.US.md)
- [VRAX.US](https://longbridge.com/en/quote/VRAX.US.md)
- [YARW.US](https://longbridge.com/en/quote/YARW.US.md)
- [PNTG.US](https://longbridge.com/en/quote/PNTG.US.md)
- [CUE.US](https://longbridge.com/en/quote/CUE.US.md)
- [ZJYL.US](https://longbridge.com/en/quote/ZJYL.US.md)
- [SPRC.US](https://longbridge.com/en/quote/SPRC.US.md)
- [BGM.US](https://longbridge.com/en/quote/BGM.US.md)
- [GCTK.US](https://longbridge.com/en/quote/GCTK.US.md)
- [LIMNW.US](https://longbridge.com/en/quote/LIMNW.US.md)

## Related News & Research

- [WORK Medical Technology Group reports Q2 results](https://longbridge.com/en/news/296110807.md)
- [Yarrow Bioscience files amended 8-K report on merger exchange ratio update](https://longbridge.com/en/news/295840217.md)
- [Silo Pharma says Canada issues notice of allowance for SPC-15 PTSD patent application](https://longbridge.com/en/news/296265804.md)
- [Silo Pharma issues 165,000 unregistered shares in asset purchase deal](https://longbridge.com/en/news/296402385.md)
- [Liminatus Pharma annual meeting draws 48.31% of shares represented](https://longbridge.com/en/news/294876806.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**